|
NFXL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.775680E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.483590E-01 |
| Normal-vs-Stage2 |
6.301200E-01 |
| Normal-vs-Stage3 |
2.815700E-04 |
| Normal-vs-Stage4 |
2.603100E-03 |
| Stage1-vs-Stage2 |
6.454200E-01 |
| Stage1-vs-Stage3 |
7.200700E-04 |
| Stage1-vs-Stage4 |
2.883800E-02 |
| Stage2-vs-Stage3 |
2.526300E-02 |
| Stage2-vs-Stage4 |
8.685700E-02 |
| Stage3-vs-Stage4 |
4.246200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.838100E-02 |
| Normal-vs-AfricanAmerican |
4.098000E-03 |
| Normal-vs-Asian |
5.729000E-01 |
| Caucasian-vs-AfricanAmerican |
1.355590E-01 |
| Caucasian-vs-Asian |
8.098400E-01 |
| AfricanAmerican-vs-Asian |
3.743400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.467800E-02 |
| Normal-vs-Female |
2.163400E-03 |
| Male-vs-Female |
1.279380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.439240E-01 |
| Normal-vs-Age(41-60Yrs) |
7.545900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.450200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.268470E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.000400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.910400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.826400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.852800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.592770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.737200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.785000E-01 |
| Normal-vs-Grade 2 |
5.272000E-01 |
| Normal-vs-Grade 3 |
9.004800E-04 |
| Normal-vs-Grade 4 |
2.23359999995676E-06 |
| Grade 1-vs-Grade 2 |
7.432200E-01 |
| Grade 1-vs-Grade 3 |
8.172400E-02 |
| Grade 1-vs-Grade 4 |
3.944700E-03 |
| Grade 2-vs-Grade 3 |
1.276020E-03 |
| Grade 2-vs-Grade 4 |
6.11110000048321E-07 |
| Grade 3-vs-Grade 4 |
1.378430E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.964600E-01 |
| Normal-vs-ccB subtype |
3.028700E-04 |
| ccA subtype-vs-ccB subtype |
1.62188999999202E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.593800E-02 |
| Normal-vs-N1 |
3.024200E-04 |
| N0-vs-N1 |
1.143630E-02 |
|
|
